2,413
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Silicon Valley, disruption, and the end of uncertainty

Pages 169-184 | Received 20 Feb 2018, Accepted 18 Sep 2019, Published online: 28 Nov 2019

References

  • Adair-Toteff, C., 2005. Max Weber’s charisma. Journal of Classical Sociology, 5 (2), 189–204.
  • Agamben, G., 2011. The kingdom and the glory: for a theological genealogy of economy and government. Stanford University Press.
  • Ausmus, H.J., 1978. Nietzsche and eschatology. Journal of Religion, 58 (4), 347–364.
  • Barbrook, R. and Cameron, A., 1996. The Californian ideology. Science as Culture, 6 (1), 44–72.
  • BBC Website 2013. FDA bans 23andme personal genetic tests. 26 Nov. Available at https://www.bbc.com/news/technology-25100878 [Accessed Nov 9 2019].
  • Bay, M., 2010. Who are the tech press darlings? An empirical study of coverage of innovation-driven tech companies in US newspapers. Innovation Journalism, 7 (7).
  • Beckert, J., 2016. Imagined futures: fictional expectations and capitalist dynamics. Cambridge, MA: Harvard University Press.
  • Beckert, J. and Bronk, R., 2018. Uncertain futures: imaginaries, narratives, and calculation in the economy. Oxford, UK: Oxford University Press.
  • Bell, E.J., et al., 2017. The platform press: how Silicon Valley reengineered journalism. Published Report, Tow Center for Digital Journalism, Columbia University.
  • Bilton, N., 2016. The secret culprit in the Theranos mess: the tech press may be as responsible as Elizabeth Holmes. Vanity Fair online edition, 2 May. Available from: https://www.vanityfair.com/news/2016/05/theranos-silicon-valley-media [Accessed 20 February 2018].
  • Brown, N., 2003. Hope against hype – accountability in biopasts, presents and futures. Science Studies 16 (2), 3–21.
  • Brown, K., 2018. How DNA testing botched my family’s heritage, and probably yours, too. Gizmodo, 16 Jan. Available from: https://gizmodo.com/how-dna-testing-botched-my-familys-heritage-and-probab-1820932637/amp?__twitter_impression=true [Accessed 19 February 2018].
  • Carreyrou, J., 2015. A prized startup's struggles — Silicon Valley lab Theranos is valued at $9 billion but isn't using its technology for all the tests it offers. Wall Street Journal, Eastern edition, 15 Oct, A.1.
  • Carreyrou, J., 2016. ‘Deficient practices’ are found At Theranos. Wall Street Journal, Eastern edition, 28 Jan, A.1.
  • Carreyrou, J., 2018. Bad blood: secrets and lies in a Silicon Valley start-up. New York: Knopf.
  • Chen, A., 2018. Theranos is finally shutting down. Investors have lost nearly $1 billion in the company. The Verge, 5 Sept. Available from: https://www.theverge.com/2018/9/5/17822680/theranos-shutdown-elizabeth-holmes-blood-test-health-science.
  • Class Action Reporter, 2017. THERANOS: court upholds fraud claims in investor class action. Vol. 19, 30 May.
  • Cole-Turner, R., 2016. Eschatology and the technologies of human enhancement. Interpretation: A Journal of Bible and Theology, 70 (1), 21–33.
  • Coleman, E.G. 2013. Coding freedom: the ethics and aesthetics of hacking. Princeton, NJ: Princeton University Press.
  • Curnutte, M., and Testa, G., 2012. Consuming genomes: scientific and social innovation in direct-to-consumer genetic testing. New Genetics and Society, 31 (2), 159–181.
  • Davies, W., 2016. The limits of neoliberalism: authority, sovereignty and the logic of competition. London: Sage.
  • DeLashmutt, M.W., 2006. A better life through information technology? The techno-theological eschatology of posthuman speculative science. Zygon, 41 (2), 267–288.
  • Deutschmann, C., 2001. Die Verheißung des absoluten Reichtums: zur religiösen Natur des Kapitalismus. Frankfurt: Campus Verlag.
  • Diamandis, E.P., 2015. Theranos phenomenon: promises and fallacies. Clinical Chemistry and Laboratory Medicine (CCLM), 53 (7), 989–993.
  • Duff, A.S., 2016. Rating the revolution: Silicon Valley in normative perspective. Information, Communication & Society, 19 (11), 1605–1621.
  • Echeverri-Carroll, E.L., et al., 2018. Unintended consequences on gender diversity of high-tech growth and labor market polarization. Research Policy, 47 (1), 209–217.
  • Esposito, E., 2013. The structures of uncertainty: performativity and unpredictability in economic operations. Economy and Society, 42 (1), 102–129.
  • Esposito, E., 2015. Beyond the promise of security: uncertainty as resource. Telos, 2015 (170), 89–107.
  • Esposito, E., 2018. Predicted uncertainty: volatility calculus and the indeterminacy of the future. In: J. Beckert and R. Bronk, eds. Uncertain futures: imaginaries, narratives, and calculation in the economy. Oxford, UK: Oxford University Press, 219–235.
  • FDA, 2013. Warning letter. Available from: https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm376296.htm [Accessed 26 January 2018].
  • FDA, 2015. Theranos warning letter. Available from: https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/default.htm?Page=1.
  • Fortun, M., 2001. Mediated speculations in the genomics futures markets. New Genetics and Society, 20 (2), 139–156.
  • Fortun, M., 2008. Promising genomics: Iceland and deCODE genetics in a world of speculation. Berkeley: University of California Press.
  • Friedman, L. F. and Loria, K. (2015). Theranos founder was 'personally shocked' about the story slamming her company today. Business Insider, Oct 16 https://www.businessinsider.com/elizabeth-holmes-fires-back-at-her-critics-2015-10?r=US&IR=T [Accessed Nov 9 2019].
  • Fukuyama, F., 1989. The end of history? The National Interest, (16), 3–18.
  • Gayá, P., and Phillips, M., 2016. Imagining a sustainable future: eschatology, Bateson’s ecology of mind and arts-based practice. Organization, 23 (6), 803–824.
  • Geiger, S., and Finch, J., 2016. Promissories and pharmaceutical patents: agencing markets through public narratives. Consumption Markets & Culture, 19 (1), 71–91.
  • Geiger, S., and Gross, N., 2017. Does hype create irreversibilities? Affective circulation and market investments in digital health. Marketing Theory, 17 (4), 435–454.
  • Geiger, S. and Gross, N., 2019. A tidal wave of inevitable data? Assetization in the consumer genomics testing industry. Business & Society (ahead of print).
  • Gottschall, J., 2016. Theranos and the dark side of storytelling. Harvard Business Review online edition. Available from: https://hbr.org/2016/10/theranos-and-the-dark-side-of-storytelling [Accessed 20 February 2018].
  • Graham, E., 2002. ‘Nietzsche gets a modem’: Transhumanism and the technological sublime. Literature and Theology, 16 (1), 65–80.
  • Hathaway, I. and Rothwell, J., 2015. A cure for health care inefficiency? The value and geography of venture capital in the digital health sector. Brookings Institute Report, 10 Sept. Available from: https://www.brookings.edu/research/a-cure-for-health-care-inefficiency-the-value-and-geography-of-venture-capital-in-the-digital-health-sector/.
  • Hogarth, S., 2017. Valley of the unicorns: consumer genomics, venture capital and digital disruption. New Genetics and Society, 36 (3), 250–272.
  • Holmes, E., 2015. How to Usher in a new era of preventive health care. Wall Street Journal, Eastern edition, 29 July, A.13.
  • Ioannidis, J.P., 2015. Stealth research: is biomedical innovation happening outside the peer-reviewed literature? Jama, 313 (7), 663–664.
  • Ioannidis, J.P., 2016. Stealth research and Theranos: reflections and update 1 year later. Jama, 316 (4), 389–390.
  • Khosla, V., 2012. Technology will replace 80 per cent of what doctors do. Fortune, 4 Dec. Available from: http://fortune.com/2012/12/04/technology-doctors-khosla/.
  • Lane, D.A. and Maxfield, R.R., 2005. Ontological uncertainty and innovation. Journal of Evolutionary Economics, 15, 3–50.
  • Levina, M., 2017. Disrupt or die: mobile health and disruptive innovation as body politics. Television & New Media, 18 (6), 548–564.
  • Loureiro, R.V., 2010. Politics and eschatology: Christian, Muslim and liberal traditions and their visions of humankind's future. College Station: Texas A&M University.
  • Meyers, G. and Van Hoyweghen, I., 2018. ‘This could be our reality in the next five to ten years’: a blogpost platform as an expectation generation device on the future of insurance markets. Journal of Cultural Economy, 11 (2), 125–140.
  • Mirowski, P., 2012. The modern commercialization of science is a passel of Ponzi schemes1. Social Epistemology, 26 (3-4), 285–310.
  • Muniesa, F., 2017. On the political vernaculars of value creation. Science as Culture, 26 (4), 445–454.
  • Nafus, D. and Sherman, J., 2014. This one does not go up to 11: the quantified self movement as an alternative big data practice. International Journal of Communication, 8, 1784–1794.
  • Pannenberg, W., 2008. Modernity, history and eschatology. In: The Oxford handbook of eschatology, ed. J.L. Walls. New York: Oxford University Press, 493–494.
  • Rago, J., 2013. Elizabeth Holmes: the breakthrough of Instant diagnosis. Wall Street Journal, 8 Sept.
  • Reinert, H. and Reinert, E.S., 2006. Creative destruction in economics: Nietzsche, Sombart, Schumpeter. In: J.G. Backhaus and W. Drechsler, eds. Friedrich Nietzsche (1844–1900). The European heritage in economics and the social sciences, Vol. 3. Boston, MA: Springer, 55–85.
  • Riesebrodt, M., 1999. Charisma in Max Weber’s sociology of religion. Religion, 29 (1), 1–14.
  • Robinson, B.T., 2013. Appletopia: media technology and the religious imagination of Steve Jobs. Waco, TX: Baylor University.
  • Schumpeter, J.A., 1968 [1934]. The theory of economic development. 8th ed. Cambridge, MA: Harvard University Press.
  • Schumpeter, J.A., 2010 [1943]. Capitalism, socialism and democracy. London: Taylor & Francis.
  • Schwarzkopf, S., 2011. The political theology of consumer sovereignty. Theory, Culture & Society, 28 (3), 106–129.
  • Scott, C.T. and DeFrancesco, L., 2015. Selling long life. Nature Biotechnology, 33 (1), 31–40.
  • Scudellari, M., 2017. Big science has a buzzword problem. Nature News, 541 (7638), 450.
  • Shiller, R., 2000. Irrational exuberance. Princeton, NJ: Princeton University Press.
  • Smith, J., 2014. ‘Silicon Valley’ fact check: HBO Nails TechCrunch disrupt all the way down to the nametags. The Observer Online. Available from: https://observer.com/2014/06/silicon-valley-fact-check-hbo-nails-techcrunch-disrupt-all-the-way-down-to-the-nametags/ [Accessed 10 October 2018].
  • Thomas, M., 2013. To claim someone has ‘Viking ancestors’ is no better than astrology. Guardian, 25 Feb. Available from: https://www.theguardian.com/science/blog/2013/feb/25/viking-ancestors-astrology [Accessed 1 July 2017].
  • Topol, E.J., 2015. The patient will see you now: the future of medicine is in your hands. Tantor Media.
  • Turrini, M. and Prainsack, B., 2016. Beyond clinical utility: the multiple values of DTC genetics. Applied Translational Genomics, 8, 4–8.
  • Weaver, C., 2016. Flawed Theranos tests Hurt Patients — Some weren't told for months that their results were dubious. Wall Street Journal, Eastern edition, 21 Oct, A.1.
  • Weaver, C., 2017a. Theranos sets pact to refund Arizonans. Wall Street Journal, Eastern edition, 19 Apr, B.3.
  • Weaver, C., 2017b. Theranos agrees to 2-year ban from blood testing. Wall Street Journal, Eastern edition, 18 Apr, B.1.
  • Weaver, C. and Siconolfi, M., 2017. Business news: Theranos low on cash after settlement. Wall Street Journal, Eastern edition, 2 Aug, B.3.
  • Weaver, C. Carreyrou, J., and Siconolfi, M., 2016. Blood lab Theranos faces criminal probe. Wall Street Journal, Eastern edition, 19 Apr, A.1.
  • Weber, M., 2019/1922. Economy and society. A new translation by K. Tribe. Cambridge, MA: Harvard University Press.
  • Winner, L., 1998. Prophets of inevitability. MIT’s Technology Review, 101, 62.
  • Woodruffe, H.R., 1997. Eschatology, promise, hope: the Utopian vision of consumer research. European Journal of Marketing, 31 (9/10), 667–676.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.